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Abstract
The molecular mechanism controlling the variable activity of the malignancy marker adenosine deaminase (ADA) is enigmatic. ADA
activity was found to be modulated by the membrane-bound adenosine deaminase complexing protein (CPMDPPIVMCD26). The role of
lipid–protein interactions in this modulation was sought. While direct solubilization of ADA in vesicles resulted in loss of ADA activity, the
binding of ADA to CP reconstituted in vesicles restored the specific activity. The activity of ADA, free or bound to CP in solution, resulted in
continuous linear Arrhenius plots. However, ADA bound to reconstituted CP exhibited two breaks associated withf30% increased activity,
at 25 and 13 jC, yielding three lines with similar apparent activation energies (Ea). Continuum solvent model calculations of the free energy
of transfer of the transmembrane helix of CP from the aqueous phase into membranes of various widths show that the most favorable
orientations of the helix above and below the main phase transition may be different. We suggest that the 20% change in the thickness of the
bilayer below and above the main phase transition may modify the orientation of CP in the membrane, thereby affecting substrate
accessibility of ADA. This could account for ADA’s reduced activity associated with increased membrane fluidity in transformed vs. normal
fibroblasts. D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Adenosine deaminase (adenosine aminohydrolase EC
3.5.4.4, ADA) catalyzes the irreversible hydrolytic deami-
nation of adenosine and 2V-deoxyadenosine to the corre-
sponding hypoxanthine derivatives, inosine and 2V-deoxy-
inosine with liberation of ammonia. ADA has polymorphic
tissue-dependent quaternary structures. In its large form, this
enzyme is a hybrid between two small 45-kDa catalytic
subunits—ADA, and one unit of a 210-kDa membrane
glycoprotein, referred to as the complexing protein (CP).
The high affinity between ADA and CP prevails even when
they originate in different species [1]. However, the physio-
logical role of the binding between CP and ADA is not yet
known [2–6]. Binding between ADA and the A1 adenosine
receptor was also reported [7]. CP, a type II membrane
protein, is a dimer. Each monomer consists of six cytoplas-
mic amino acids followed by a transmembrane span of
22 residues and an extracellular glycoprotein [8]. In the
absence of X-ray crystallographic data, the exact binding
site of ADA on CP is still unknown. It has been proposed
that the binding occurs at the glycosylated region on CD26,
between amino acids 294 and 441 [9]. Recently, we reported
that CP from calf kidney is identical with human, mouse and
rat dipeptidylpeptidase IV (DPPIV, EC 3.4.14.5), known as
the T-cell activation antigen CD26 [10]. CP has no deami-
nating activity in itself, yet, DPPIV cleaves X-proline or
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X-alanine dipeptide from the N-terminal ends of polypep-
tide chains [5,6,9,10].
CP is expressed on a variety of cell types, particularly
epithelial cells of the intestine, prostate and kidney proximal
tubules [11,12]. In contrast, the expression of CD26 on T
cells is regulated stringently. The molecule is absent from
the majority of human resting peripheral blood T lympho-
cytes and is expressed weakly on a fraction of T cells in the
blood. Expression increases with T-cell activation. Thus,
CD26 is a marker for T cells activated in vivo [13]. CD26
was also characterized as a key molecule in the regulation of
activation and proliferation of natural killer cells, and is
considered to be an activation marker also of B cells [14]. In
addition, CD26 is a potential cancer marker [15] and is
associated with interaction with collagen and/or fibronectin,
the pathogenesis of diseases such as adult periodontitis,
diabetes, AIDS and breast cancer, and it is an adherence
molecule in metastasis [5,6,13,14,16].
ADA is an established malignancy marker displaying
anomalous, mostly decreased activity in several cancers
[1,11,17–21]. However, there is at present no mechanistic
model to account for the variable activity of ADA in normal
vs. transformed cells. We reported that CP modifies ADA
activity in buffer solution [11,22]. A possible modulatory
role for CP on ADA activity in normal and virally trans-
formed chick embryo fibroblast (CEF), using spectroscopic
techniques, was also revealed [1]. The fluidization of the
plasma membrane of transformed cells was ascribed to the
amount of cholesterol and extent of unsaturation of the
phospholipids [23–27]. Reduced ADA activity in trans-
formed cells was associated with reduced fluorescence
anisotropy and decreased rotational correlation time of
1,6-diphenyl-1,3,5-hexatriene (DPH) labeled CEF plasma
membrane, indicating increased membrane fluidity. It was
suggested that the reduced order in the plasma membrane of
transformed cells allows sinking of CP into the lipid core
thus reducing its accessibility to externally added ADA. The
same trend in ADA activity and membrane order parameters
was observed in vesicles enriched with variable cholesterol
concentrations, in which CP was reconstituted [21,23].
However, the mechanistic interpretation of these data is
complicated because of the possible involvement of specific
cholesterol–protein interactions [28], in addition to a bulk
viscosity effect. To reduce the complexity of the system, we
explore here whether changes in lipid–protein interactions,
i.e., alterations in the dynamic properties of the plasma
membrane [21,23] induced by temperature, affect the activ-
ity of the ADA-CP complex reconstituted in lipid vesicles;
could lipid–protein interactions provide a regulatory mech-
anism for the activity of this enzyme?
Frequently, it was impossible to distinguish between the
effect of membrane dynamics (i.e., fluidity and order) on
observed activity and that of temperature per se [29–31].
This limitation stems from the fact that most membrane
proteins catalyze vectorial reactions or transport processes
that can be assayed only within a vesicular system and not
when stripped of their lipidic milieu. The present system
however provides us with the unique opportunity to study
the effect of temperature on the activity of ADA free or
bound either to delipidated CP, i.e., in buffer solution, or to
CP incorporated into a lipid bilayer. Thus, we used Arrhe-
nius plots of ADA activity in the presence and absence of
CP and lipids to discern between membrane-mediated
temperature effects on ADA activity and direct temperature
effects on catalysis.
2. Materials and methods
2.1. Materials
All reagents and solvents were analytical grade or purer.
Adenosine deaminase (high purity grade, from calf intestine,
approximately 200 unit/mg protein) was purchased from
Sigma Chemical Co. as an ammonium sulfate suspension. It
was estimated to be at least 90% pure 45,000 Mr subunit by
SDS-PAGE [11]. Ammonium sulfate was removed by
dialysis against three changes of 10 volumes of PBS (154
mM NaCl and 10 mM sodium phosphate buffer, pH 7.5).
BSA (fraction V, 96–99%), adenosine and inosine were
purchased from Sigma. DMPC, 99%+ (lyophilized) was
purchased from Avanti, Polar-Lipids Inc. FITC was pur-
chased from Molecular Probes. [8-14C]-Adenosine, specific
activity 56.1 mCi/mmol, was purchased from NEN. DEAE
cellulose ion exchange chromatography paper (DE-81) was
obtained from Whatman. TLC was carried out on aluminum
sheets of silica gel 60 F 254 pre-coated (5 7.2 cm, 0.2 mm
thick), from Merck.
2.2. Experimental methods
2.2.1. Adenosine deaminase activity: spectrophotometric
assay
The enzymatic activity of stock solutions was determined
by a spectrophotometric assay [1] on a HP 8452A Diode
Array spectrophotometer following the drop in absorbance
of adenosine to inosine at 265 nm. Linear rates of deami-
nation were recorded in the presence of 0.7–50 AM adeno-
sine in PBS (at 25 jC). Under these conditions, one unit of
ADA deaminates 1 Amol of adenosine per minute. The
standard error for the activity measurements was 2%.
2.2.2. Adenosine deaminase activity: radiometric assay
Rates of enzymatic deamination were measured by a
radiometric assay, according to Coleman and Hutton [32]
with a few modifications as described previously [21],
following the conversion of [14C]adenosine to [14C]inosine
with time, cooling over the temperature range of 7–35 jC.
Thermally equilibrated samples and 50 AM adenosine (f 2
AM [14C]adenosine) were mixed in a final volume of 1 ml.
The reactions were stopped at increasing time intervals of 2
up to 22 min by the addition of 50 Al 5 N formic acid, then
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vortexed. Each sample was then spotted (20 Al) on DE-81
chromatography paper, on which standard solutions (3 mg/
ml) of adenosine and inosine were loaded at the origin. The
paper was developed (2.5–3 h) in ammonium formate by
descending chromatography. After drying overnight, the
spots of adenosine and inosine were cut and counted in a
Beckman LS 1800 scintillation h counter. The amount of
inosine produced was calculated after blank subtraction,
using a specific activity of 124,542 cpm/nmol. After plot-
ting the amount of inosine produced as a function of time,
initial rates were calculated from the linear portion of the
curve at each temperature. The natural logarithm of enzyme
activity calculated from these slopes were plotted as a
function of the inverse of the absolute temperature, yielding
the Arrhenius plots shown in Results.
2.2.3. Preparation of sonicated DMPC vesicles
Lyophilized DMPC phospholipids were first taken up in
CHCl3/CH3OH, (9:1, v/v). The organic solvent was eva-
porated under nitrogen. Last traces were removed by re-
dissolving the lipids in a minimum of diethyl ether and
drying with nitrogen. Lipids were homogenized in argon-
saturated PBS in a Bellco Dounce Homogenizer. Aliquots of
2 ml were bath or tip sonicated. Tip sonication, done at a
70% duty cycle, was carried out with a Sonicatork Ultra-
sonic Processor (Heat Systems-Ultrasonics Inc., 375 W),
equipped with a tapered microtip of 3 mm diameter. Bath
sonication was performed in a Sonicor bath. All sonications
were carried out above the main phase transition temper-
ature (Tm) of the lipids [33]. Unsonicated lipids and/or
titanium dispersed particles were separated by centrifuga-
tion in an Eppendorf microcentrifuge (9980 g) for 15
min. Residual unsonicated lipids were extracted three times
with CHCl3/CH3OH (9:1, v/v), (f 5 ml each time). The
extracts were combined and the solvent evaporated under
nitrogen. The residue, dissolved in a minimum of diethyl
ether, was dried and weighted. The actual concentration of
the lipids in the liposomes was determined from the weight
difference between the sonicated and unsonicated lipids.
The lipid vesicles were stored in sealed vials in the
presence of 0.02% NaN3, above Tm. Vesicles were checked
by Silica Gel 60F254 pre-coated TLC plates (UV and
sulfuric acid) for the presence of fatty acids and lysocho-
line with two elution systems: (1) chloroform/methanol/
ammonia (conc.) 64:28:5, v/v; (2) chloroform/methanol/
acetic acid/water 25:15:4:2 v/v. Only those vesicles that
showed a single spot with either elution mixtures were
used.
2.2.4. Dynamic light scattering (DLS) measurements
Measurements were carried out on a Malvern 4700/SM
photon correlation spectrometer (Precision Devices and
System Ltd., Malvern). The sample cell was thermostated
at 30.00F 0.01 jC, i.e., above the Tm of the vesicles. Data
processing was made by Malvern software package based
cumulant analysis. The diffusion coefficients, measured by
DLS, were used to determine the hydrodynamic radius (rh)
of the vesicles [34]. Vesicles were checked daily. The mean
size diameter distribution before freeze–thaw was 62.6F
15.3 nm; more than 95% of all vesicles prepared were in the
size range below 100 nm diameter. After freeze–thaw,
vesicle size increased to 125F 56 nm.
2.2.5. Purification of CP
Bovine kidneys used for all preparations were between 1
and 3 years of age. The procedure was essentially that of
Weisman et al. [11], employing an ADA-bound affinity
column. Since the CP–ADA complex consist of one CP and
two ADA molecules, at least one binding site on CP must
be free for binding ADA in the ADA-affinity column.
Therefore, the number of molecules of ADA that can bind
one molecule of CP maybe one or two. The dialyzed sample
was concentrated 100-fold using an Amicon ultrafiltration
apparatus under nitrogen (2 atm) employing a PM 30 KD
DIAFLO membrane. A standard preparation yielded 12–15
mg of protein. Samples were stored at 4 jC in the presence
of 0.02% NaN3. Following isolation and purification, the
CP solution is clear and no aggregates are detected for
several weeks. Routinely, prior to use, CP solutions are
centrifuged in order to clarify the supernatant from any
build-up of aggregates which might have been formed
during storage at 4 jC. The protein thus obtained was iden-
tical to that purified before [11] according to gradient (5–
15% T, 0.5% C, 0.5 mm) SDS-PAGE: without pre-boiling, a
single band of approximately 200 kDa is observed. How-
ever, when an identical sample in SDS is pretreated by
boiling for 3 min, the 200 kDa complex breaks into 110 and
70 kDa (with a minor band of 45 kDa, rising from traces of
still bound ADA) components. This observed complexation
is probably not due to disulfide linkage because boiling of
the sample in the absence or presence of dithiothreitol elicits
identical results [10,11]. Thus, the isolated CP is dimeric in
nature.
2.2.6. Reconstitution of CP in DMPC vesicles
Purified CP was reconstituted by the freeze– thaw
method of Kasahara and Hinkle [35]. The fraction of CP
reconstituted in a single freeze–thaw cycle was about 50%.
Higher yields were achieved in a two step freeze–thaw. A
standard reconstitution mixture contained 1 mg of CP and
12–15 mg of lipids. An average molar ratio of 4800:1 lipid
to CP was maintained in order to achieve, in two steps of
freeze–thaw, high reconstitution yields [33]. Thus, with
0.8–1.1 mg CP and initial weight ratio of 10–15 lipid to
CP (w/w), the total protein recovery amounted to 93F 4%
and the reconstitution yield averaged at 81F12% (n = 10;
reconstitution yield (%)=[mg protein in vesicles/(mg protein
in supernatant +mg protein in vesicles)] 100). CP is
dimeric in nature and has no tendency to aggregate. Thus,
based on the ratio of CP/lipids, the estimated area of a
single phospholipid headgroup of 56 A˚2, and the size of
the vesicles, we estimate that each vesicle may contain
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about 110,000 phospholipids and 20 CP molecules. There-
fore, the chance for multimeric CP to occur was very
slim. Control vesicles were prepared without CP. A brief
bath sonication (30 s) was carried out to break up
aggregates that might have been formed during freeze–
thaw. Reconstituted and control vesicles were centrifuged
at 130,000 g for 3 h above the Tm of the lipids ( > 23
jC). Supernatants containing the unincorporated protein
were collected. The clear pellets were gently re-suspended
in 1 ml of PBS (under argon), containing 0.02% NaN3.
The catalytic activity of ADA was assessed in a cuvette
containing 1 ml of buffer with the variable concentrations
of the adenosine substrate preincubated to the required
temperature. At time zero, 30–50 Al of vesicle samples
were mixed instantaneously (the equilibrium temperature
remained unchanged, as assessed by a thermocouple) and
the initial rates of ADA activity was determined. Thus, the
20–30-fold dilution renders vesicle fusion unlikely. The
reconstituted vesicles were stored above the Tm of the
lipids.
2.2.7. Binding of FITC-ADA to reconstituted CP
FITC-ADA was prepared as described before [1]. The
protein content of FITC-ADA preparations was generally
0.8–1 mg/ml; the activity of the labeled enzyme ranged
from 90 to 110 unit/ml (at 25 jC). An FITC-ADA to CP
molar ratio of at least 4:1 was used for binding studies.
Incubation was carried out above the Tm of the lipids in a
total volume of 1 ml PBS (under argon) for 1 h in the
dark. Blank samples of vesicles (with and without pro-
tein) to which no FITC-ADA was added, were also pre-
pared. Excess FITC-ADA was separated by ultracentrifu-
gation at 130,000 g for 3 h, as described above. After
washing the pellets twice in PBS (under argon), the
supernatants were collected and the pellets resuspended
in 1 ml of PBS. Protein content and FITC-ADA activity
assays were carried out, on both supernatants and resus-
pended pellets.
2.2.8. Steady-state fluorescence spectroscopy
Relative fluorescence emission spectra were carried out
on the Perkin-Elmer MPF-44 spectrofluorometer, equip-
ped with a bath thermostated cell holder, 4 nm slits, at
280 (protein) and 493 (fluorescein) nm excitation wave-
lengths. Samples were checked for inner filter effect
(OD< 0.2).
2.2.9. DPH fluorescence polarization and lifetime measure-
ments
Vesicles were labeled with DPH in the dark for 1 h at
room temperature (or above the Tt of lipids) according to
Shinitzky and Inbar [36]. The lipid/DPH molar ratio was
greater than 1000:1. Fluorescence emission spectra of DPH
were recorded at 360 nm excitation [24,26]. Blank back-
ground fluorescence at 430 nm (emission maximum of
DPH) was less than 4%. Fluorescence anisotropy (r) was
measured at 30 jC by a SLM 4800 spectrofluorometer in
the T-configuration, as described before [37].
2.2.10. Protein assay
A modified Lowry assay, carried out in the presence of
1% SDS [35] was used to quantify protein content in
vesicles and buffer samples, using BSA as the standard.
2.3. Computational methods
The membrane environment usually induces secondary
structure formation in peptides (e.g., White and Wimley
[38]; Kessel and Ben-Tal [39]). Thus, it was assumed that
like most membrane-spanning segments of integral mem-
brane proteins, the transmembrane span of CP adapts an a-
helical conformation. Our goal was to determine the effect
of the main liquid-to-gel phase transition at about 24 jC in
the membrane on the most likely orientation of the helix in
the bilayer. To this end, an atomic model of the trans-
membrane region of CP in a-helix form was built. Con-
tinuum solvent model calculations [40–42] were used to
estimate the free energy of transfer of the helix from the
aqueous phase into lipid bilayers with hydrophobic cores
of 28 and 33 A˚, i.e., above and below the main phase
transition temperature in DMPC vesicles, respectively (Ole
G. Mouritsen, personal communication). These calcula-
tions were used to predict the most likely orientation of
the helix in the bilayer at each of the two thicknesses. That
is, the orientations associated with the most negative value
of the free energy of transfer of the peptide into the
bilayer.
2.3.1. Peptide
The model is the 23 amino acid peptide (VLLGLLG-
AAALVTIITVPVLLN), corresponding to CP (residues 7–
29), that includes the transmembrane region of the enzyme
according to the annotations in the SWISS-PROT protein
sequence database [43]. Most membrane-spanning segments
of integral membrane proteins are a-helical [38,44] and we
therefore assumed that the CP(7–29) peptide exists in
a-helix conformation. A model of the peptide was built
(Biopolymer) and energy minimized using 200 steepest
descent iterations and the CVFF force field in DISCOVER
(Molecular Simulations, San Diego, CA). Since the CP
segment is part of a polypeptide, its termini was considered
uncharged for our calculations.
2.3.2. Membranes
The bilayers were represented as a slab of dielectric
constant (e) 2, and widths 28 and 33 A˚, corresponding to
the width of the hydrophobic core of DMPC membranes
above and below the main phase transition temperature,
embedded in the high dielectric constant of water (e = 80).
The value of 2, assigned to the dielectric constant of mem-
brane, is known from a combination of thickness and capaci-
tance measurements [45,46].
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2.3.3. Free energy determinants of CP(7–29) insertion into
membranes
The free energy of transfer of CP(7–29) from the aque-
ous phase into a lipid bilayer was calculated as described in
our earlier studies (e.g., Ben-Tal et al. [47]; Kessel et al.
[48]). The total free energy difference between CP(7–29) in
the bilayer and in the aqueous phase (DGtot) was calculated
as the sum of solvation contributions (DGsolv), lipid pertur-
bation effects (DGlip) and peptide immobilization effects
(DGimm).
DGtot ¼ DGsolv þ DGlip þ DGimm: ð1Þ
The insertion process may also involve free energy
changes resulting from a change in the conformation of
CP(7–29). However, such changes should not affect the
conclusions significantly, because they most likely appear in
both the 28 A˚ and the 33 A˚ width membranes and should
therefore cancel out.
2.3.4. The calculation of DGsolv
DGsolv is the free energy of transfer of CP(7–29) from
water to a bulk hydrocarbon phase. It can be written as a
sum of electrostatic (DGelec) and nonpolar (DGnp) contribu-
tions:
DGsolv ¼ DGelec þ DGnp: ð2Þ
We calculated DGsolv using a continuum solvent model.
The transmembrane region of CP(7–29) was represented in
atomic detail; each atomic nucleus was assigned a partial
charge and a radius, using PARSE [49]. The lipid bilayer
was represented as a slab of dielectric constant of 2. The
system was then mapped onto a (1293) grid and the Pois-
son equation was solved to obtain DGelec. DGnp is pro-
portional to the water accessible surface area buried in the
bilayer.
2.3.5. Estimates of DGlip and DGimm
DGlip is the free energy penalty resulting from the
interference of CP(7–29) with the conformational freedom
of the lipid bilayer chains. DGimm is the free energy penalty
resulting from the confinement of the external translational
and rotational motion of CP inside the membrane. We
calculated DGlip = 2.3 kcal/mol and DGimm = 3.7 kcal/mol
for the insertion of a polyalanine a-helix into a membrane
of 30 A˚ width [47,50]. Since DGlip and DGimm are an order
of magnitude smaller than DGsolv, their change, due to the
change in membrane width (28 vs. 33 A˚), should be
secondary to the change in solvation. Thus, since the change
in the membrane width is small, we used the estimates given
above, which were calculated for an average membrane
width of 30 A˚.
3. Results
3.1. Experimental results
3.1.1. Binding of ADA to CP reconstituted in DMPC
vesicles
It was suggested that CP preserves ADA activity upon
sequestering ADA to the cell surface [1]. Specific binding
of small subunit ADA to CP reconstituted in DMPC
vesicles was studied both by steady-state fluorescence of
FITC labeled ADA and by the protein (CP and/or ADA)
tryptophan fluorescence. Fig. 1 depicts fluorescein (A) and
tryptophan (B) fluorescence emissions for FITC-ADA-CP-
vesicles (spectra I). The difference between spectra I and III
in Fig. 1B stems from the contribution of bound ADA. The
nonspecific binding of FITC-ADA in control vesicles (with-
out CP) averaged at 7.2F 1.1% (meanF S.E., n = 10) of the
binding of FITC-ADA to CP-vesicles (Fig. 1A, spectrum
II). This was further observed by the fluorescence emission
of the protein (Fig. 1B, spectrum II). The amount of bound
ADA and the binding to reconstituted CP were calculated
from the concentration of FITC-ADA (mg/ml) (Fig. 1A,
spectra I minus II) by using a calibration curve of fluo-
rescein fluorescence (510 nm) vs. protein concentration of
FITC-ADA.
3.1.2. Effect of CP on ADA activity and fluorescence ani-
sotropy of DPH
We aimed at evaluating the modulatory effects CP
presumably has on ADA activity and the role lipid–protein
Fig. 1. (A) Fluorescence emission spectra of fluorescein labeled ADA
(FITC-ADA) in the following reconstitution systems: I. FITC-ADA bound
to reconstituted ADCP in DMPC vesicles. II. FITC-ADA added to plain
DMPC vesicles. III and IV are the control of samples I and II, respectively,
i.e., without FITC-ADA; kex = 493 nm. (B) Protein fluorescence for the
above samples; kex = 280 nm (tryptophan). The amount of bound ADA and
the binding to reconstituted CP were calculated based on the following
determinations: the concentration of FITC-ADA (mg/ml) was calculated
from the net fluorescein fluorescence at 510 nm ((A) spectra (I) minus (II))
using a calibration curve of fluorescein fluorescence vs. protein concen-
tration of FITC-ADA.
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interactions may play on such modulation. The fluorescence
anisotropy (r) and lifetime (s) measurements of the lip-
ophilic DPH, showed that r(DPH) almost doubled upon CP
reconstitution in vesicles (Table 1, columns 4 vs. 6), while
lifetime, s = 8.5F 0.5 ns, did not change [51,52]. These
findings suggest a strong rigidifying effect upon the sur-
rounding phospholipids. Binding of ADA to DMPC vesi-
cles with and without reconstituted CP had no additional
effect on r(DPH) (columns 6, 7 vs. 4, 5).
The minute ADA that bound to CP-free vesicles (Fig. 1)
lost most of its specific activity (Table 1, column 5, assays
IV and V). However, when bound to vesicles following
reconstitution of CP, the catalytic activity was fully retained
(Table 1 column 7, assays IV and V vs. column 2, assay III).
Similar results were obtained in asolectin vesicles (Table 1,
legend). Different anisotropy values for DMPC and asolec-
tin vesicles in which CP was reconstituted, were observed
(Table 1 column 7, assay I vs. II). Nevertheless, in spite of
the difference in r(DPH), the specific activities of ADA were
similar (Table 1 column 7, assays IV and V). These suggest
that other factors, in addition to membrane order parameter,
reflected by the value of r(DPH), are important in controlling
lipid–protein interactions. Hydrophobic mismatching due to
changes in membrane width [53] could add to the tuning
effects CP may exert on ADA activity. In contrast, in buffer
CP inhibits ADA activity by 50% (Table 1, column 3 vs. 2)
as was already shown before by Weisman et al. [11] and
Cohen-Luria et al. [22]. These results show strong and
variable changes in ADA-specific activity upon binding to
CP, be it in buffer or in vesicles. Moreover, in addition to
these protein–protein interactions, the change in r(DPH)
upon CP reconstitution reflects the influence of the sur-
rounding lipids on the observed modulatory effect on ADA.
3.1.3. Arrhenius plots of ADA activity
Arrhenius plots of the activity of free small subunit ADA
and of the complex ADA-CP, assayed radiometrically in
PBS, are shown in Fig. 2. Linear plots over the temperature
range studied are observed, with essentially the same
apparent Ea, 15.5F 0.9 and 14.4F 0.8 kcal/mol for ADA
and ADA-CP, respectively. On the contrary, the Arrhenius
plot of ADA bound to reconstituted CP in DMPC vesicles
(Fig. 3) exhibits two break points, at about 24 and 13 jC,
yielding three nearly parallel lines, with no change in Ea,
12.8F 0.8 kcal/mol. These temperatures correlate well with
the main phase transition temperature at f 24 jC and of the
pretransition temperature at f 13 jC, reported for DMPC
Table 1
Binding of ADA to CP alters ADA specific activity: solvation effect
Assay Buffer Vesicles
CP +CP CP +CP
ADA +ADA ADA +ADA
1 2 3 4 5 6 7
r(DPH)
a in (I) DMPC vesicles 0.089F 0.004 0.090F 0.004 0.160F 0.008 0.177F 0.009
(II) asolectin vesicles 0.108F 0.006
Specific activity in (III) buffer 105F 10b 52.90F 3.45c
44.85F 5.75b
(IV) DMPC vesicles 7.73F 1.30 120F 12
(V) asolectin vesicles 8.20F 2.85 100F 10
Data presented are meanF S.D. of three experiments each run in duplicate. r(DPH) measurements
a were run at 30 jC. ADA activity, in unit/mg ADA, was
assessed spectrophotometricallyb, measuring the decrease in the absorbance of adenosine at 265 nm and radiometricallyc, using [14C]-adenosine. SS-ADA,
4 nM, was preincubated with 40 nM CP, for 1 h at 37 jC with 0.7–50 AM adenosine. ADA specific activity in vesicles was assessed as described in Materials
and methods using a calibration curve of fluorescein fluorescence vs. protein concentration of FITC-ADA. The mean rh values determined by DLS for asolectin
vesicles, prepared similarly, were 59.0F 14.7 nm before and 66.2F 17.4 nm after freeze– thawing. CP reconstitution yield after two freeze– thaw cycles
averaged at 69F 15% (n= 5) using 0.7–1.6 mg CP and initial weight ratio of 8–17 lipid to CP (w/w). Total protein recovery amounted to 96F 4%.
Fig. 2. Temperature dependence of ADA activity in PBS. Arrhenius plots of
the activity of free small subunit ADA (empty circles) and of the CP-ADA
complex (filled circles). At each temperature maximal rates (Amol/sec) were
assayed by the radiometric method (see Materials and methods). Each data
point is the mean of three independent runs, and bars indicate their standard
deviations.
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vesicles by DPH fluorescence polarization [54]. At each of
these discontinuities, an abrupt rate increase of f30%
relative to the extrapolated rate values of the declining
temperature curve was observed.
3.2. Computational results
We calculated DGtot, the free energy of insertion of
CP(7–29) in a-helical conformation into lipid bilayers with
hydrocarbon regions of widths 28 and 33 A˚, as described in
Computational methods. In each case, we sampled around
an orientation where the principle axis of CP(7–29) was
normal to the membrane plane and found the orientation
associated with the most negative free energy. The most
negative DGtot values, i.e., the values associated with the
most probable transmembrane configurations of CP(7–29)
in membranes with hydrocarbon regions of widths 28 and 33
A˚ ( 16 and  12 kcal/mol, respectively) are presented in
Table 2 along with the free energy decompositions. The
values of DGtot are significantly more negative than the
value of about  5 kcal/mol obtained for the membrane
insertion of a 25 mer polyalanine a-helix into a 30 A˚ lipid
bilayer [47], which is expected, given the highly hydro-
phobic nature of the transmembrane region of CP. The
results suggest that CP exists almost exclusively in its
membrane-bound form, in agreement with experimental
data [5,6].
The results also suggest a difference in the orientation of
CP in membranes with hydrocarbon region of 33 A˚ com-
pared to its orientation in a 28-A˚ membrane; tilt angles of
f 0j and f 20j, respectively (Table 2). The 20j difference
in the tilt angle between the two orientations is, for the most
part, due to the mismatch between the length of the hydro-
phobic region of CP(7–29) and the thickness of the hydro-
carbon region of the membrane. Experimental evidence [8]
as well as our calculations show that the hydrophobic region
of CP is a stretch of 22 residues between Val7 to Lys28. In
a-helix conformation, this stretch gives a hydrophobic
region of about 33 A˚ length. This length is compatible with
the width of the hydrocarbon region of the membrane in the
gel phase, which is characterized by elongated acyl chains
(on average). However, in the liquid phase, where the acyl
chains are, on average, shorter and the hydrocarbon region
of the membrane is only about 28 A˚ wide, parts of the
hydrophobic stretch, CP(7–28), may be exposed to the
aqueous solution. The f 20j tilt facilitates the immersion
of these surfaces in the hydrocarbon region of the 28 A˚
width bilayer and increases the favorable nonpolar interac-
tions between CP and the bilayer. It is thus suggested that
the effective length of the CP transmembrane domain fits
better with the elongated acyl chain in the gel phase rather
than with the shorter chains in the liquid phase.
4. Discussion
The present study was aimed at elucidating the solvent
effects upon the binding of ADA to CP on ADA activity.
The environmental dependence of the regulatory role of CP
on ADA activity suggests that one important function of CP
is to sequester ADA to the membrane while preserving its
activity. Thus, direct lipid solubilization of ADA results in
the abrupt loss of ADA-specific activity. In buffer, however,
the binding of ADA to CP resulted in about 50% reduction
in activity relative to free ADA (Table 1). Binding of ADA
specifically to reconstituted CP restores the specific activity
of ADA (Fig. 1), while at the lipid phase transition, a 30%
increase in ADA activity occurred (Fig. 3). It is proposed
that the immediate environment tunes the modulatory effect
of CP on ADA activity. The finding that CP, either in
DMPC or asolectin vesicles, in spite of the difference in
r(DPH), exerts a similar effect on the specific activity of ADA
(Table 1) is rather intriguing. These findings have led us to
suggest that other factors in addition to membrane order
parameter, reflected by the fluorescence anisotropy values
of DPH, are important in controlling lipid–protein interac-
tions. Thus, hydrophobic mismatching due to changes in
membrane width [53,55] could add to the tuning effects CP
may exert on ADA activity.
A conventional analysis of the effect of temperature on
enzyme activities relies on the dependence of the catalytic
step on temperature as revealed by Arrhenius plot. For most
enzyme-catalyzed reactions, Ea is constant over a narrow
temperature range. However, for most membrane enzymes,
a departure from linearity is usually obtained [56]. These
deviations can take the form of actual breaks in the curve or
a sudden change in enzyme activation energy, without a
change in reaction rate at a distinctive temperature. Usually,
one observes a decrease in Ea upon increasing the temper-
ature above the temperature of the break. The origin of such
deviations has been a matter of controversy [57–59]. Yet,
most abrupt changes in the measured Ea are attributed to a
change in the physical state of the membrane, most notably,
changes in membrane fluidity/order parameter and thickness
caused by a phase transition of the lipids. The system
studied here presents an essentially constant Ea above and
below the phase transition temperatures, at each of which,
an abrupt rate increase takes place. A similar abrupt rate
increase was reported for h-galactoside transport in E. coli
Table 2
Free energy and orientation of CP in lipid bilayers
Membrane Tilt angle DGelc
c DGnp
d DGsolv
e DGimm
f DGlip
g DGtot
h
width (A˚)a (j)b
(kcal/mol)
28 f 20 24  46  22 3.7 2.3  16
33 f 0 38  56  18 3.7 2.3  12
aThe width of the hydrocarbon region of the membrane. bThe tilt angle of
CP with respect to the normal of the lipid bilayer. cThe electrostatic and
dnonpolar contributions to ethe solvation free energy (Eq. (2)). fThe peptide
immobilization free energy. gThe lipid perturbation free energy. hThe total
free energy.
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[60]. The observation that Ea of the reconstituted system
remains unaltered through all the temperature range studied
(Fig. 3), similar to that observed with ADA or ADA-CP in
buffer (Fig. 2), implies that the turnover number of ADA is
independent of the changes in lipid viscosity over the
temperature range studied. Membrane domain formation
during lipid phase transitions may play a role in the
distribution of transmembrane proteins [61]. This could lead
perhaps to the data in Fig. 3. While this possibility could not
be excluded, Yuli et al. [62] described the dependence of
carrier-mediated glucose transport on lipid ‘‘microviscos-
ity.’’ They claimed it to be valid for the overt activity of
membrane-bound enzymes as well. Based on their proposal,
lipid phase transitions may change the accessibility to sub-
strate, which presumably results in the abrupt rate increase
at the phase and the pre-phase transitions as evident here.
The transition of phospholipids bilayer from a liquid to
gel phase is associated with a marked change in membrane
dimension, while the bilayer arrangement and integrity are
preserved. The gauche-to-trans isomerization of the acyl
chains during this transition gives rise to a decrease of
approximately 15% in chain area and an increase of approx-
imately 20% in membrane thickness [63]. Recent small-
angle neutron diffraction experiments show that the width of
the hydrocarbon region of the membrane changes from 28 to
33 A˚ during the main phase transition (Ole G. Mouritsen,
personal communication). The hydrophobic length of the
transmembrane segment of CP in a-helix conformation
(f 33 A˚) is similar to the width of the hydrocarbon region
of the membrane in the gel phase (33 A˚), but longer than the
width of the hydrocarbon region of the membrane in the
liquid phase (28 A˚). Our calculations show that the mismatch
between the hydrophobic lengths of the CP(7–28) trans-
membrane helix and the membrane width facilitates a change
in the orientation of the helix in the membrane above and
below the lipid phase transition (Table 2). We suggest that
the observed difference in the activity of ADA above and
below the main phase transition at f 24 jC may be caused
by changes in substrate accessibility to ADA, which in turn
may be due to changes in the orientation of the ADA-CP
complex in the bilayer. Since there is no large change in lipid
thickness at the pre-phase transition at 13 jC, a possible
explanation to the observed break in ADA activity may be
due to a reorientation of polar headgroups associated with the
Lh to PhV transition, presumably leading to charge redistrib-
ution [54]. This may further restrict protein flexibility by
interacting better with the hydrophilic part of the CP at the
interface, reducing to minimum the hydrophobic mismatch-
ing. These additional changes in the orientation of the ADA-
CP complex in the bilayer could result in further reduction of
the accessibility of the active site of ADA to its substrate
adenosine.
To sum up, this paper suggests that differences in protein–
membrane (CP, to which ADA is bound) interactions above
and below the pre- and main-phase transitions in the bilayer,
result in a tilt (relative to the membrane normal) in the ADA-
CP complex. The net effect is that the bound ADA is thereby
transformed from a configuration in which its active site is
readily accessible to the substrate (adenosine or deoxyade-
nosine), to a configuration in which tilting results in getting
ADA bathed (i.e., partially buried) in the phospholipid head-
groups. Thereby, it is rendered less accessible to the substrate.
The reduced activity of ADA associated with cell trans-
formation in CEF, alluded to in the Introduction, may thus
be explained.
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